KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Next generation CAR-T cells - Dr Bruce Levine on-demand webinar

Dr Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, leads a webinar on the extended range and next generation CAR-T cells. Watch the full webinar presentation, as well as seven other on-demand webinars, here.

Playfully subtitled Clinical development of CAR-T cells: From “It’s impossible” to “I knew it was a good idea all along”, the presentation was part of Cell & Gene Therapy Manufacturing & Commercialization Digital Week. Dr Levine explains:

"Since the 1990’s, we have conducted clinical trials of gene modified T cells. Chimeric antigen receptor (CAR) T cells targeting CD19 on B cells leukemias and lymphomas have induced durable complete responses in patients who are relapsed or refractory to all other available treatments.

This technology has now undergone global multi-center clinical trials. CAR-T cells targeting new targets in hematologic malignancies and in solid tumors are underway and provide demonstration that it is possible to design immunity at will for therapeutic application."

CLICK HERE to watch the full presentation, as well as seven other on-demand webinars from the Cell Therapy Manufacturing and Gene Therapy Digital Week.

Get articles like this by email